Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMOP
BNY Mellon Municipal Opportunities ETF
BMOP
|
+$1.73B |
| 2 |
BKMI
BNY Mellon Municipal Intermediate ETF
BKMI
|
+$1.63B |
| 3 |
AstraZeneca
AZN
|
+$1.19B |
| 4 |
Texas Instruments
TXN
|
+$836M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$744M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.06B |
| 2 |
Apple
AAPL
|
+$1.49B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Bank of America
BAC
|
+$859M |
| 5 |
TSMC
TSM
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Financials | 11.85% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
InfuSystem Holdings
INFU
$244M
| $601K | ﹤0.01% |
65,079
-11,856
| -15% | -$103K |
|
3477
iShares World ex U.S. Carbon Transition Readiness Aware Active ETF
LCTD
$296M
| $598K | ﹤0.01% |
10,813
-151
| -1% | -$8.59K |
|
3478
Enlight Renewable Energy
ENLT
$11.9B
| $597K | ﹤0.01% |
8,751
+30
| +0.3% | +$1.92K |
|
3479
iShares JPMorgan EM Corporate Bond ETF
CEMB
$413M
| $597K | ﹤0.01% |
13,192
+7,410
| +128% | +$340K |
|
3480
Capital Group Global Growth Equity ETF
CGGO
$12.1B
| $597K | ﹤0.01% |
+17,879
| New | +$636K |
|
3481
Lufax Holding
LU
$1.31B
| $595K | ﹤0.01% |
318,365
+14,224
| +5% | +$35.9K |
|
3482
PUT
Accenture
ACN
$109B
| $595K | ﹤0.01% |
3,000
| – | – |
|
3483
Conduent
CNDT
$241M
| $594K | ﹤0.01% |
463,965
-24,711
| -5% | -$37.7K |
|
|
ACH
3484
Accendra Health
ACH
$84.6M
| $592K | ﹤0.01% |
259,792
-12,762
| -5% | -$29.4K |
|
|
VOXR
3485
Vox Royalty Corp
VOXR
$369M
| $592K | ﹤0.01% |
112,945
-3,493
| -3% | -$18.7K |
|
|
CMRC
3486
Commerce.com Inc Series 1
CMRC
$179M
| $591K | ﹤0.01% |
221,369
-6,949
| -3% | -$21.6K |
|
|
REMG
3487
Russell Investments Emerging Markets Equity ETF
REMG
$124M
| $590K | ﹤0.01% |
19,163
+2,180
| +13% | +$69.7K |
|
3488
Evolus
EOLS
$536M
| $588K | ﹤0.01% |
143,164
+5,367
| +4% | +$26K |
|
|
WLTH
3489
Wealthfront Corp
WLTH
$1.4B
| $587K | ﹤0.01% |
+63,492
| New | +$581K |
|
3490
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.45B
| $587K | ﹤0.01% |
5,956
-156
| -3% | -$16K |
|
|
RNA
3491
Atrium Therapeutics
RNA
$208M
| $584K | ﹤0.01% |
+43,697
| New | +$614K |
|
3492
Core Molding Technologies
CMT
$224M
| $583K | ﹤0.01% |
26,042
-898
| -3% | -$17.7K |
|
3493
Greene County Bancorp
GCBC
$601M
| $580K | ﹤0.01% |
25,861
-902
| -3% | -$20.5K |
|
3494
Arcturus Therapeutics
ARCT
$223M
| $579K | ﹤0.01% |
74,997
-1,304
| -2% | -$9.52K |
|
3495
Rezolute
RZLT
$453M
| $579K | ﹤0.01% |
189,779
-481,913
| -72% | -$1.45M |
|
|
NMAX
3496
Newsmax Inc
NMAX
$1.14B
| $578K | ﹤0.01% |
110,775
+5,283
| +5% | +$35.6K |
|
3497
Shattuck Labs
STTK
$735M
| $577K | ﹤0.01% |
89,774
-20,620
| -19% | -$97.8K |
|
|
FRMI
3498
Fermi Inc
FRMI
$4.21B
| $577K | ﹤0.01% |
98,819
+64,369
| +187% | +$563K |
|
3499
Anika Therapeutics
ANIK
$295M
| $577K | ﹤0.01% |
39,767
-738
| -2% | -$8.57K |
|
3500
Frontier Group Holdings
ULCC
$1.54B
| $575K | ﹤0.01% |
162,761
-34,287
| -17% | -$157K |
|
Similar funds
Bank of New York Mellon's Q1 2026 Portfolio in Review
As of Q1 2026, Bank of New York Mellon held 4,358 positions worth $544B, down 4.2% from $568B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q1 2026 filing shows 177 new, 1,536 increased, 2,374 reduced and 164 closed positions. Its largest new stake was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B. The largest sale was Vanguard S&P 500 ETF, an estimated $2.06B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q1 2026 buy was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B.
- Bank of New York Mellon added most to AstraZeneca in Q1 2026, an estimated $1.19B increase.
- Bank of New York Mellon's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.06B.
- Bank of New York Mellon fully exited Comerica in Q1 2026, selling an estimated $293M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $544B portfolio in Q1 2026.
- Bank of New York Mellon opened 177 new positions and closed 164 in Q1 2026.
- Bank of New York Mellon's portfolio value fell 4.2% quarter-over-quarter to $544B.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.